Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2024 Filed Feb 21, 2024 00:27 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · derivative · entry 6 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:27 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 195 | $24.29 | $4,736.55 |
DisclosureSEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · nonDerivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,675 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:27 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 475 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · nonDerivative · entry 3 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:27 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 67 | $24.29 | $1,627.43 |
DisclosureSEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,395 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:27 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:28 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 475 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000016 · wk-form4_1708475269.xml · derivative · entry 6 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,371 Underlying: Common Stock · 475 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F6 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. F6 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:28 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000016 · wk-form4_1708475269.xml · derivative · entry 5 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:28 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Tax withholdingCommon Stock | 162 | $24.29 | $3,934.98 |
DisclosureSEC source: 0001438133-24-000016 · wk-form4_1708475269.xml · nonDerivative · entry 4 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,157 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:28 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionCommon Stock | 475 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000016 · wk-form4_1708475269.xml · nonDerivative · entry 3 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:28 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Tax withholdingCommon Stock | 56 | $24.29 | $1,360.24 |
DisclosureSEC source: 0001438133-24-000016 · wk-form4_1708475269.xml · nonDerivative · entry 2 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,844 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:28 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionCommon Stock | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000016 · wk-form4_1708475269.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:27 UTC |
Carpenter RickChief Technology Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 596 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000015 · wk-form4_1708475253.xml · derivative · entry 3 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,978 Underlying: Common Stock · 596 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:27 UTC |
Carpenter RickChief Technology Officer
|
Tax withholdingCommon Stock | 245 | $24.29 | $5,951.05 |
DisclosureSEC source: 0001438133-24-000015 · wk-form4_1708475253.xml · nonDerivative · entry 2 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,840 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:27 UTC |
Carpenter RickChief Technology Officer
|
Exercise / conversionCommon Stock | 596 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000015 · wk-form4_1708475253.xml · nonDerivative · entry 1 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,085 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:26 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000011 · wk-form4_1708475167.xml · derivative · entry 6 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,182 Underlying: Common Stock · 2,236 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F6 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. F6 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:26 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 793 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000011 · wk-form4_1708475167.xml · derivative · entry 5 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,962 Underlying: Common Stock · 793 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:26 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 917 | $24.29 | $22,273.93 |
DisclosureSEC source: 0001438133-24-000011 · wk-form4_1708475167.xml · nonDerivative · entry 4 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,362 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:26 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Stock | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000011 · wk-form4_1708475167.xml · nonDerivative · entry 3 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:26 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 325 | $24.29 | $7,894.25 |
DisclosureSEC source: 0001438133-24-000011 · wk-form4_1708475167.xml · nonDerivative · entry 2 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,043 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:26 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Stock | 793 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000011 · wk-form4_1708475167.xml · nonDerivative · entry 1 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:26 UTC |
Hansen Shannon MarieChief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 531 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000010 · wk-form4_1708475152.xml · derivative · entry 4 Hansen Shannon Marie · CIK 0001908267 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,246 Underlying: Common Stock · 531 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Awarded on February 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:26 UTC |
Hansen Shannon MarieChief Legal Officer
|
Tax withholdingCommon Stock | 218 | $24.29 | $5,295.22 |
DisclosureSEC source: 0001438133-24-000010 · wk-form4_1708475152.xml · nonDerivative · entry 2 Hansen Shannon Marie · CIK 0001908267 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,576 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:26 UTC |
Hansen Shannon MarieChief Legal Officer
|
Exercise / conversionCommon Stock | 531 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000010 · wk-form4_1708475152.xml · nonDerivative · entry 1 Hansen Shannon Marie · CIK 0001908267 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:06 UTC |
Sodhi RajwantDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000002 · wk-form4_1704747950.xml · derivative · entry 2 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,070 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: RSUs granted on January 4, 2021. The total number of shares subject to the RSU vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: RSUs granted on January 4, 2021. The total number of shares subject to the RSU vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:06 UTC |
Sodhi RajwantDirector
|
Exercise / conversionCommon Stock | 1,070 | $27.66 | $29,596.20 |
DisclosureSEC source: 0001438133-24-000002 · wk-form4_1704747950.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:18 UTC |
Novara Mark DavidEVP & CHIEF COMMERCIAL OFFICER
|
GrantRestricted Stock Unit · Derivative | 88,975 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000258 · wk-form4_1703020671.xml · derivative · entry 1 Novara Mark David · CIK 0002000342 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,975 Underlying: Common Stock · 88,975 shares Expires not disclosed F1 · security: Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). F1 · derivative.exercise_price: Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). F2 · derivative.exercise_date: Restricted stock units (RSU) vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. F2 · derivative.expiration_date: Restricted stock units (RSU) vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:14 UTC |
Carpenter RickChief Technology Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000257 · wk-form4_1703020435.xml · derivative · entry 3 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,247 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Awarded on December 15, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 12/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 12/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:14 UTC |
Carpenter RickChief Technology Officer
|
Tax withholdingCommon Stock | 141 | $28.63 | $4,036.83 |
DisclosureSEC source: 0001438133-23-000257 · wk-form4_1703020435.xml · nonDerivative · entry 2 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,489 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:14 UTC |
Carpenter RickChief Technology Officer
|
Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000257 · wk-form4_1703020435.xml · nonDerivative · entry 1 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 16:09 UTC |
Leal JamesChief Manufacturing Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000247 · wk-form4_1701292166.xml · derivative · entry 3 Leal James · CIK 0001866570 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 619 Underlying: Common Stock · 310 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 16:09 UTC |
Leal JamesChief Manufacturing Officer
|
Tax withholdingCommon Stock | 129 | $19.47 | $2,511.63 |
DisclosureSEC source: 0001438133-23-000247 · wk-form4_1701292166.xml · nonDerivative · entry 2 Leal James · CIK 0001866570 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,113 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 16:09 UTC |
Leal JamesChief Manufacturing Officer
|
Exercise / conversionCommon Stock | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000247 · wk-form4_1701292166.xml · nonDerivative · entry 1 Leal James · CIK 0001866570 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:09 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000246 · wk-form4_1701292152.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 745 Underlying: Common Stock · 373 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:09 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Tax withholdingCommon Stock | 129 | $19.47 | $2,511.63 |
DisclosureSEC source: 0001438133-23-000246 · wk-form4_1701292152.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,805 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:09 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionCommon Stock | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000246 · wk-form4_1701292152.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:08 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000243 · wk-form4_1701292086.xml · derivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 813 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:08 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 141 | $19.47 | $2,745.27 |
DisclosureSEC source: 0001438133-23-000243 · wk-form4_1701292086.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,299 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:08 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000243 · wk-form4_1701292086.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:10 UTC |
Allen DickDirector
|
PurchaseCommon Stock | 5,000 | $18.96 | $94,777.50 |
DisclosureSEC source: 0001438133-23-000250 · wk-form4_1701292228.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,962 Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:10 UTC |
BERGER DAVID BEVP & Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000249 · wk-form4_1701292197.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 813 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:10 UTC |
BERGER DAVID BEVP & Chief Operating Officer
|
Tax withholdingCommon Stock | 141 | $19.47 | $2,745.27 |
DisclosureSEC source: 0001438133-23-000249 · wk-form4_1701292197.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,338 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:10 UTC |
BERGER DAVID BEVP & Chief Operating Officer
|
Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000249 · wk-form4_1701292197.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:09 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000248 · wk-form4_1701292178.xml · derivative · entry 3 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,639 Underlying: Common Stock · 820 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:09 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 284 | $19.47 | $5,529.48 |
DisclosureSEC source: 0001438133-23-000248 · wk-form4_1701292178.xml · nonDerivative · entry 2 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,575 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:09 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Stock | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000248 · wk-form4_1701292178.xml · nonDerivative · entry 1 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:09 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000245 · wk-form4_1701292127.xml · derivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 813 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:09 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Tax withholdingCommon Stock | 135 | $19.47 | $2,628.45 |
DisclosureSEC source: 0001438133-23-000245 · wk-form4_1701292127.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,622 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:09 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000245 · wk-form4_1701292127.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:08 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000244 · wk-form4_1701292109.xml · derivative · entry 3 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 813 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:08 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Tax withholdingCommon Stock | 116 | $19.47 | $2,258.52 |
DisclosureSEC source: 0001438133-23-000244 · wk-form4_1701292109.xml · nonDerivative · entry 2 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,737 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.